ADJUVANT CHEMOTHERAPY FOR POOR PROGNOSIS ESTROGEN-RECEPTOR NEGATIVE STAGE-II STAGE-III BREAST-CANCER ONE YEAR VS 2 YRS CMFVP

被引：0
|
作者：
RIVKIN, S
GREEN, S
METCH, B
OSBORNE, CK
KNIGHT, WA
MCDIVITT, R
CRUZ, A
TESH, D
COSTANZI, J
BALCERZAK, S
STEVENS, R
机构：
[1] SW ONCOL GRP,SEATTLE,WA 98104
[2] SW ONCOL GRP,SAN ANTONIO,TX 78229
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY FOR POOR PROGNOSIS ESTROGEN-RECEPTOR NEGATIVE STAGE-II, STAGE-III BREAST-CANCER ONE YEAR VS 2 YRS CMFVP
    RIVKIN, S
    GREEN, S
    METCH, B
    OSBORNE, CK
    KNIGHT, WA
    MCDIVITT, R
    CRUZ, A
    TESH, D
    COSTANZI, J
    BALCERZAK, S
    STEVENS, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 80 - 80
  • [2] ADJUVANT CHEMOTHERAPY FOR STAGE-II AND STAGE-III BREAST-CARCINOMA
    CAPRINI, JA
    OVIEDO, MA
    CUNNINGHAM, MP
    COHEN, E
    TRUEHEART, RS
    KHANDEKAR, JD
    SCANLON, EF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (03): : 243 - 246
  • [3] ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN STAGE-II OR STAGE-III BREAST-CANCER 5-YEAR RESULTS
    BUZDAR, AU
    BLUMENSCHEIN, GR
    LEGHA, SS
    HORTOBAGYI, GN
    YAP, HY
    SMITH, TL
    HERSH, EM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 144 - 144
  • [4] ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    RIVKIN, S
    GLUCKSBERG, H
    RASMUSSEN, S
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 353 - 353
  • [5] THE ROLE OF SERUM CEA AS A PROGNOSTIC INDICATOR IN STAGE-II AND STAGE-III BREAST-CANCER PATIENTS TREATED WITH ADJUVANT CHEMOTHERAPY
    THERIAULT, RL
    HORTOBAGYI, GN
    FRITSCHE, HA
    FRYE, D
    MARTINEZ, R
    BUZDAR, AU
    [J]. CANCER, 1989, 63 (05) : 828 - 835
  • [6] ADJUVANT CHEMOTHERAPY WITH AND WITHOUT RADIOTHERAPY IN STAGE-II BREAST-CANCER
    BRUFMAN, G
    SULKES, A
    BIRAN, S
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (05) : 351 - 355
  • [7] IDENTIFICATION OF PATIENTS WITH POOR PROGNOSIS STAGE-II BREAST-CANCER
    OREILLY, SM
    CAMPLEJOHN, RS
    HOWELL, A
    RUBENS, RD
    RICHARDS, MA
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 449 - 449
  • [8] ADJUVANT HORMONO-CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    HOLT, S
    DESOUSA, BA
    BRADLEY, S
    LEINSTER, SJ
    GEORGE, WD
    [J]. BRITISH JOURNAL OF SURGERY, 1984, 71 (05) : 390 - 390
  • [9] TAMOXIFEN VERSUS CHEMOTHERAPY AS ADJUVANT TREATMENT IN STAGE-III BREAST-CANCER
    ALAGARATNAM, TT
    WONG, J
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1986, 56 (01): : 39 - 41
  • [10] ADJUVANT CHEMOTHERAPY (CMF) FOR STAGE-III BREAST-CANCER - A RANDOMIZED TRIAL
    DERMAN, DP
    BROWDE, S
    KESSEL, IL
    DEMOOR, NG
    LANGE, M
    DANSEY, R
    SEYMOUR, L
    BEZWODA, WR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02): : 257 - 261
12345